Stay Tuned!

Subscribe to our newsletter to get our newest articles instantly!

Tech News

Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer Patients


— Twenty-five institutions collaborate with Cofactor to validate OncoPrism for use in head and neck cancer patients.

SAINT LOUIS, Mo.–(BUSINESS WIRE)–November 17, 2023–

Cofactor Genomics, the company bridging the precision medicine gap, today announced successful validation of the OncoPrism immunotherapy predictive diagnostic assay, enabling physicians to use the test to help guide treatment decisions for patients with metastatic or recurrent squamous cell carcinoma of the head and…



Source link

Avatar

Techy Nerd

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like

Tech News

3 ways businesses can strike the ideal marketing and IT balance

We’re seeing two schools of thought emerge on how best to leverage data in the digital media landscape. The first
Software Tech News

Build Smart Biolinks with AI: Introducing the AI Biolink Creator

AI powered content for Bio Links and Marketing.